Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.

Abstract

Adeno-associated virus (AAV) shows significant potential as a gene delivery system. Although it is ubiquitous in its distribution, with approximately 85% of the adult population in the United States seropositive for the virus, it has never been associated with clinical disease. Not only is AAV non-pathogenic, but it can infect with high efficiency both… (More)

Topics

Cite this paper

@article{During1995AdenoassociatedVV, title={Adeno-associated virus vectors for gene therapy of neurodegenerative disorders.}, author={M J During and Paola Leone}, journal={Clinical neuroscience}, year={1995}, volume={3 5}, pages={292-300} }